TickerFacts.

ADC Therapeutics SA (ADCT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

127.07M
Year ended 2025-12-31
+17.6%
3-year compound annual growth
2022-12-31: 78.15M2023-12-31: 81.71M2024-12-31: 97.16M2025-12-31: 127.07M127.07M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31127.07M+30.8%2026-03-10, From 2025-01-01
2024-12-3197.16M+18.9%2026-03-10, From 2024-01-01
2023-12-3181.71M+4.6%2025-03-27, From 2023-01-01
2022-12-3178.15Mn/a2024-03-13, From 2022-01-01